Literature DB >> 1572492

Three-dimensional architectures of peritoneal endometriosis.

J Donnez1, M Nisolle, F Casanas-Roux.   

Abstract

OBJECTIVE: To elucidate some biological characteristics of peritoneal endometriosis.
DESIGN: A recently advanced stereographic computer technology was applied for the investigation of the three-dimensional (3-D) architectures of peritoneal endometriosis.
SETTING: University Hospital of Gynecology. PATIENTS: Biopsies were taken from 42 women with peritoneal endometriosis. Twenty-six of them were in the luteal phase. Seventeen of them received Zoladex (ICI, Cambridge, United Kingdom) for 12 weeks before biopsy.
RESULTS: Two different main types could be identified according to the presence or absence of ramifications. The apparently multifocal occurrence (in 2-D) of glandular epithelium was not confirmed by the 3-D study that showed that all epithelial glands are interconnected by luminal structures in each peritoneal lesion. Stereometric study suggests a stronger effect of gonadotropin-releasing hormone agonist therapy on the stroma than on the epithelium.
CONCLUSIONS: The study evaluated the 3-D architectures of peritoneal endometriosis and identified two principal types of peritoneal endometriosis.

Entities:  

Mesh:

Year:  1992        PMID: 1572492

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

Review 1.  Pathogenesis and pathophysiology of endometriosis.

Authors:  Richard O Burney; Linda C Giudice
Journal:  Fertil Steril       Date:  2012-07-20       Impact factor: 7.329

2.  Endometriosis.

Authors:  E J Thomas
Journal:  BMJ       Date:  1993-01-16

3.  Impaired Expression of Membrane Type-2 and Type-3 Matrix Metalloproteinases in Endometriosis but Not in Adenomyosis.

Authors:  Jane B Maoga; Muhammad A Riaz; Agnes N Mwaura; Georgios Scheiner-Bobis; Ezekiel Mecha; Charles O A Omwandho; Ivo Meinhold-Heerlein; Lutz Konrad
Journal:  Diagnostics (Basel)       Date:  2022-03-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.